TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer.

Vinay Varadan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.